It is a complex metabolic disease characterized by insulin resistance, progressive beta-cell dysfunction, chronic inflammation, and an increased risk of cardiovascular disease, kidney disease, neuropathy, retinopathy, and other long-term complications
18, 19 Although the effects of GLP-1 on pancreatic endocrine cells have been well studied, there is little information on the effects of GLP-1R in other pancreatic exocrine tissues that might be involved in inflammatory conditions of the pancreas
147, no
Pancreatic exocrine insufficiency may occur in up to 30% of the patients within three years of an episode of AP[23]
demonstrated that BPC-157 promoted angiogenesis in healing tissues through upregulation of VEGF (vascular endothelial growth factor) and related growth factors (6)
[Google Scholar] Akhtar, M